Notably, consistent with in vitro cellular results and subcutaneous xenograft results, depletion of BAP1 significantly inhibits the growth of implanted tumor cells, but overexpression of MYCN partially rescued BAP1 depletion-mediated cells growth retardation (Fig. 3K and Supplementary Fig. 3D). Here, MYCN is linked to neoplasm.